💡 GORDON J. W. BEATTIE 💡

Our purpose is to help the world’s energy transition through wind power.  As the world decarbonises, demand for renewable energy, especially wind power, is soaring. In response, the scale and sophistication of renewable energy projects is increasing. Yet, the wind services market is highly fragmented, with many experienced but small thinly capitalised players needing support to grow and respond to expected demand. Venterra is building a best-in-class services company to meet this demand. We are acquiring and integrating select companies in the sector, adding our management expertise and capital to fuel expansion.   Asset-light and technology driven, with a truly collaborative culture, Venterra is helping its Group companies scale rapidly.

Babcock is a FTSE 100 defence company operating in our focus countries of the UK, Australasia, Canada, France and South Africa, with exports to additional markets. Our Purpose, to create a safe and secure world, together, defines our strategy. We support and enhance our customers’ defence and security capabilities and critical assets through a range of product and service solutions. We meet our customers’ requirements of value for money, increased availability, modernisation and flexibility. These projects take all different kinds of professionals, from chartered engineers and project managers, to naval architects, data analysts and everything in between. To bring through the next generation of engineering and business experts, we offer apprenticeships and roles for students, graduates and fully-qualified professionals. There’s never been a better time to join us. Whether you’re looking for a new business management project or engineering role, join Babcock and grow with us. Babcock is a Disability Confident, Committed Employer

Belluscura Health is a privately held U.S. medical technology company specializing in advanced oxygen enrichment and respiratory care solutions. Following the acquisition of Belluscura LLC’s assets and brand, Belluscura Health builds on a proven foundation of innovation to improve respiratory health and enhance quality of life. Headquartered in Texas, we design and develop next-generation portable oxygen devices that deliver greater freedom, mobility, and confidence to people living with Chronic Obstructive Pulmonary Disease (COPD) and other respiratory conditions. Our mission is to empower millions to breathe easier and live better, through intelligent design, clinical performance, and a commitment to patient-centered innovation.

S4Capital plc is the tech-led, new age/new era digital advertising and marketing services company, established by Sir Martin Sorrell in May 2018. Its strategy is to build a purely digital advertising and marketing services business for global, multinational, regional, local clients, and millennial-driven influencer brands. This will be achieved by integrating leading businesses in three practice areas: Content, Data&digital media and Technology services, along with an emphasis on "faster, better, more efficient" executions in an always-on consumer-led environment, with a unitary structure. In 2018, S4Capital combined with MediaMonks, the leading AdAge A-listed creative digital content production company led by Victor Knaap and Wesley ter Haar and then with MightyHive, the market-leading digital media solutions provider for future thinking marketers and agencies, led by Peter Kim and Christopher S. Martin. Since then, MediaMonks and MightyHive have combined with more than 25 companies across Content, Data&digital media and Technology services. For a full list, go to s4capital.com. In August 2021, S4Capital launched its unitary brand by merging MediaMonks and MightyHive into Media.Monks. As the operational brand, Media.Monks underpins S4Capitals agility, digital knowledge and efficiency and is the next step in delivering on its foundational promise to unify Content, Data&digital media and Technology services. Victor Knaap, Wesley ter Haar, Christopher Martin, Scott Spirit and Mary Basterfield all joined the S4Capital Board as Executive Directors. The S4Capital Board also includes Rupert Faure Walker, Paul Roy, Daniel Pinto, Sue Prevezer, Elizabeth Buchanan, Naoko Okumoto, Margaret Ma Connolly, Miles Young and Colin Day.

Our purpose is to help the world’s energy transition through wind power.  As the world decarbonises, demand for renewable energy, especially wind power, is soaring. In response, the scale and sophistication of renewable energy projects is increasing. Yet, the wind services market is highly fragmented, with many experienced but small thinly capitalised players needing support to grow and respond to expected demand. Venterra is building a best-in-class services company to meet this demand. We are acquiring and integrating select companies in the sector, adding our management expertise and capital to fuel expansion.   Asset-light and technology driven, with a truly collaborative culture, Venterra is helping its Group companies scale rapidly.

Stubben Edge is a technology-based financial services group that enables intermediaries and their clients to make easy decisions about their risks and how to protect or save against them, putting their success at the heart of everything we do so people can get back to what really matters. Its two businesses include Lucid UX, which tailors software, data and analytics solutions for clients across multiple regulated sectors. For those clients Stubben Edge Risk leverages its relationships, actuarial and product knowledge to develop niche products alongside both intermediaries and financial institutions.

Jaywing Part of the Stubben Edge Group We’re an award-winning creative, media and data agency. Powered by science, enabled by tech, obsessed with results – we’ve helped brands turn data into sharp ideas and smart strategies for over 25 years. What makes us unique? We started as a data science business. So, the power of information has shaped the way we think since day one. Today, we’re at the forefront of AI-driven innovation through our in-house Accelerator Lab. Unlocking performance for clients such as Yorkshire Tea, Pizza Express, first direct and more. We describe our approach as “stories written with numbers”. A unique combination of bold creative ideas, hard data, precision media and smart strategy. Leads, conversions, brand recognition – whatever your goal, we engineer campaigns that shift the numbers that count.

Babcock is a FTSE 100 defence company operating in our focus countries of the UK, Australasia, Canada, France and South Africa, with exports to additional markets. Our Purpose, to create a safe and secure world, together, defines our strategy. We support and enhance our customers’ defence and security capabilities and critical assets through a range of product and service solutions. We meet our customers’ requirements of value for money, increased availability, modernisation and flexibility. These projects take all different kinds of professionals, from chartered engineers and project managers, to naval architects, data analysts and everything in between. To bring through the next generation of engineering and business experts, we offer apprenticeships and roles for students, graduates and fully-qualified professionals. There’s never been a better time to join us. Whether you’re looking for a new business management project or engineering role, join Babcock and grow with us. Babcock is a Disability Confident, Committed Employer

Belluscura Health is a privately held U.S. medical technology company specializing in advanced oxygen enrichment and respiratory care solutions. Following the acquisition of Belluscura LLC’s assets and brand, Belluscura Health builds on a proven foundation of innovation to improve respiratory health and enhance quality of life. Headquartered in Texas, we design and develop next-generation portable oxygen devices that deliver greater freedom, mobility, and confidence to people living with Chronic Obstructive Pulmonary Disease (COPD) and other respiratory conditions. Our mission is to empower millions to breathe easier and live better, through intelligent design, clinical performance, and a commitment to patient-centered innovation.